Memorial Sloan Kettering Clinical Application of CAR T Cells 2019
Thursday, March 14, 2019 - Friday, March 15, 2019
CME Provider:
Memorial Sloan Kettering Cancer Center › MSK CME 633 3rd Ave, 12th Floor New York, New York (NY) 10017 United States
Phone: 646-227-2025
Visit the CME Provider Webpage ›
Conference Center:
Zuckerman Research Center › 417 East 68th Street New York, New York (NY) 10065 United States
Phone: 800-525-2225
Visit the Conference Center Webpage ›
Description:
Chimeric antigen receptor (CAR) T-cell ("Living Drug") immunotherapy is showing promising results in the treatment of cancers. There are nine ongoing clinical trials (Phase I & II) at Memorial Sloan Kettering (MSK) and more are on track to be initiated next year. Over the years, MSK has accumulated a breadth of knowledge about developing and translating these clinical trials from bench to bedside – choosing the ideal antigen target, constructing clinical grade CARs and vectors, investigating CARs in clinically relevant models, manufacturing, quality control, developing protocols for FDA approval, optimizing consent forms that cover emerging ethical issues, managing complications, and conducting world-class correlative science.
MSK faculty, along with national and international experts, will discuss the clinical and translational aspects of cell therapies (CARs, TCRs, NKs), both for hematologic malignancies and solid tumors.
Visit the CME Course Webpage › View the Course Brochure ›
Instructors:
MSK Course Director: Prasad S. Adusumilli, MD, FACS, FCCP
MSK Course Co-Directors: Renier J. Brentjens, MD, PhD Michel Sadelain, MD, PhD
CME Credit:
Physicians: 15.25 Hours
Self Assessment Module (SAM):
No
Specialty Audience:
Allergy / Immunology Internal Medicine Obstetrics / Gynecology Otolaryngology Pediatrics
RADLIST Course #19654
|
Map of
Zuckerman Research Center, 417 East 68th Street, New York, New York (NY), United States
|
|
Show Nearby:
Rank By:
|
|
|
|
|
|